Ebola Outbreak: WHO Declares Global Emergency as Congo Faces Deadly New Strain
- The World Health Organization (WHO) has declared a Public Health Emergency of International Concern (PHEIC) following a deadly outbreak of Ebola virus disease (EVD) in the Democratic Republic...
- As of May 18, 2026, the WHO reports 88 confirmed deaths and 336 suspected cases in the DRC’s Ituri province, with the virus now detected in three health...
- The current strain, Orthoebolavirus zairense, is one of the deadliest known variants of Ebola, with historical fatality rates reaching up to 90% in untreated cases.
The World Health Organization (WHO) has declared a Public Health Emergency of International Concern (PHEIC) following a deadly outbreak of Ebola virus disease (EVD) in the Democratic Republic of the Congo (DRC), with confirmed cases now spreading to neighboring Uganda. The announcement, made on May 17, 2026, marks the first global health emergency declaration for Ebola since the devastating 2014–2016 West Africa outbreak, which killed over 11,000 people. The current strain—identified as Orthoebolavirus zairense, or the Zaire ebolavirus—has already claimed at least 87 lives and infected hundreds, raising alarms over its potential to spiral into a regional crisis.
As of May 18, 2026, the WHO reports 88 confirmed deaths and 336 suspected cases in the DRC’s Ituri province, with the virus now detected in three health zones. The outbreak has crossed borders for the first time, with a confirmed case reported in Uganda’s Goma city—home to over a million people—amid concerns that armed groups controlling parts of the region may hinder containment efforts. The WHO’s director-general, Dr. Tedros Adhanom Ghebreyesus, expressed “grave concern” over the outbreak’s rapid spread, noting that the declaration was triggered by the risk of international transmission, particularly given the lack of a licensed vaccine for this specific strain.
Why This Outbreak Is Different—and More Dangerous
The current strain, Orthoebolavirus zairense, is one of the deadliest known variants of Ebola, with historical fatality rates reaching up to 90% in untreated cases. Unlike previous outbreaks, this one is unfolding in a conflict zone, where movement restrictions, armed group activity, and weak healthcare infrastructure pose major obstacles to control. The WHO emphasized that the outbreak’s proximity to major urban centers—including Goma, a transportation hub—heightens the risk of widespread transmission.
To date, no vaccine has been approved for this specific strain, though the WHO is accelerating research into repurposing existing Ebola vaccines (such as the rVSV-ZEBOV vaccine used in past outbreaks) or developing new ones. Meanwhile, public health agencies are scrambling to deploy rapid response teams, contact tracing, and infection prevention measures in affected areas. The DRC’s Ministry of Health has raised alert levels at border crossings, while Uganda has activated emergency protocols to monitor travelers from high-risk zones.
Key Challenges in Containing the Outbreak
The WHO and partners face three critical hurdles:
- Armed conflict and insecurity: The Ituri region is controlled in part by the March 23 Movement (M23), a rebel group backed by Rwanda. The WHO has warned that armed groups may obstruct medical teams, delay case reporting, or even target healthcare workers—a tactic seen in past outbreaks.
- Urban spread: Goma’s dense population and role as a regional trade hub could accelerate transmission if the virus gains a foothold. Unlike rural outbreaks, urban Ebola spreads faster due to close contact in markets, hospitals, and public transport.
- Diagnostic and treatment gaps: While oral rehydration and supportive care can improve survival rates, Ebola requires specialized isolation units and trained staff. The DRC’s healthcare system, already strained by decades of conflict, lacks the capacity to handle a large-scale epidemic.
In response, the WHO has deployed 100 international experts to the DRC, including epidemiologists, lab technicians, and logisticians. The African Centers for Disease Control (Africa CDC) is coordinating cross-border surveillance with Uganda, Rwanda, and South Sudan, while global partners like Médecins Sans Frontières (MSF) are setting up treatment centers. However, funding remains a bottleneck: the WHO’s emergency appeal for $48 million has only secured 15% of required resources.
What the Public Should Know: Symptoms, Transmission, and Prevention
Ebola virus disease (EVD) begins with flu-like symptoms—high fever, severe headache, muscle and joint pain, and weakness—followed by vomiting, diarrhea, rash, and in later stages, internal and external bleeding. Transmission occurs through direct contact with bodily fluids (blood, vomit, feces) of infected individuals or contaminated surfaces. The virus does not spread through casual contact, air, or water.
Prevention relies on barrier precautions:
- Avoiding contact with sick or deceased individuals in high-risk areas.
- Washing hands frequently with soap or using alcohol-based sanitizers.
- Avoiding raw bushmeat in regions where Ebola circulates among wildlife.
- Following travel advisories from national health authorities.
For travelers, the U.S. Centers for Disease Control (CDC) and WHO advise monitoring updates from health agencies and avoiding nonessential travel to Ituri province, and Goma. Those returning from affected areas with Ebola symptoms should seek immediate medical evaluation and inform healthcare providers of their travel history.
Looking Ahead: Will This Become a Global Crisis?
While the WHO has not yet declared a global health emergency (the highest alert level), the risk of regional spread is “very real,” according to Africa CDC. The organization is closely monitoring:

- Whether the virus mutates to become more transmissible.
- The effectiveness of contact tracing in high-mobility urban areas.
- Potential spillover into neighboring countries with weaker health systems.
- Global vaccine and treatment research timelines.
Historically, Ebola outbreaks have been contained within months if aggressive containment measures are deployed early. However, the current outbreak’s intersection with armed conflict, urban centers, and vaccine gaps makes it uniquely challenging. The WHO’s declaration serves as a call to action for global solidarity, funding, and technical support—without which, experts warn, the window to contain this outbreak may close quickly.
For now, the focus remains on local containment, but the world is watching closely. As Dr. Tedros stated, “This is a wake-up call. We cannot afford complacency.”
